权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

DETERMINING THE ROLE OF THE REPLICATIVE HELICASE IN HUMAN NK CELL DEVELOPMENT

确定复制解旋酶在人类 NK 细胞发育中的作用

基本信息

批准号：
9790924
负责人：
Emily Margaret Mace
金额：
$ 40.27万
依托单位：
COLUMBIA UNIVERSITY HEALTH SCIENCES
依托单位国家：
美国
项目类别：
财政年份：
2018
资助国家：
美国
起止时间：
2018-09-24 至 2023-08-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9790924
关键词：
Affect Antiviral Agents Antiviral Response Apoptosis Biological CD34 gene CDC45L gene CRISPR/Cas technology Cell Compartmentation Cell Cycle Cell Cycle Arrest Cell Cycle Regulation Cell Differentiation process Cell Maturation Cell Proliferation Cell division Cell physiology Cells Cellular biology Characteristics Clinical Complex DNA DNA Damage DNA biosynthesis Data Defect Development Disease Effector Cell Flow Cytometry Gene Expression Gene Expression Profiling Generations Genes Genetic Transcription Health Hematopoietic Stem Cell Transplantation Hematopoietic stem cells Heterogeneity Homeostasis Human Immune Immune response Immunologic Deficiency Syndromes Immunologics Impairment In Vitro Lead Light Lymphocyte Lymphocyte Subset Lymphoid Lymphoid Cell Lytic MCM10 gene MCM4 gene Malignant Neoplasms Mediating Modeling Molecular Mutation Natural Killer Cells Nature Outcome Pathogenicity Pathway interactions Patients Phase Phenotype Play Precursor Natural Killer Cell Predisposition Process Proteins Regulation Replication Initiation Role Structure System Testing Therapeutic Translating Transplantation Tumor Immunity Viral Virus Diseases Work cell motility cohort graft vs host disease helicase human disease immune reconstitution insight novel peripheral blood prevent response single cell analysis single-cell RNA sequencing success tool

项目摘要

PROJECT SUMMARY This proposal builds upon exciting new paradigm defined by isolated human NK cell deficiency resulting from hypomorphic mutations in multiple structural components of the eukaryotic DNA helicase. The discovery of multiple patient cohorts with a strikingly similar NK cell phenotype, namely that of impaired terminal maturation leading to susceptibility to severe viral infection and malignancy, underscores the impact of these mutations on human NK cell development and function. Despite this compelling new insight driven by human disease, the requirement for the DNA helicase complex specifically in NK cell function has not been defined. In the proposed work, we will define this requirement in the context of NK cell differentiation and proliferation to make important advances in both NK cell biology and human health. Despite their documented requirement in determining the outcome and success of transplantation, NK cell development and acquisition of function is poorly understood. A powerful tool in defining requirements for human NK cell differentiation is the study of patients with monogenic causes of impaired NK cell maturation leading to isolated NK cell deficiency (NKD). Using this approach, we and others have identified novel NKD resulting from mutations in the CDC45-MCM-GINS DNA helicase complex and associated proteins. In the proposed work, we will define the requirement for the CMG complex and, more broadly, proliferation and cell division in human NK cell development. Specifically, we will 1) define the effect of CMG helicase mutations on peripheral blood subset heterogeneity using single cell RNA sequencing and unbiased quantitative flow cytometry. Furthermore, we have 2) developed a model for patient mutations that will allow us to dissect the effect of these mutations on NK cell differentiation from earliest precursor to mature cell. We will use this, combined with our validated in vitro NK cell differentiation system, to dissect the mechanism by which hypomorphic CMG mutations affect human NK cell development and acquisition of lytic function. Finally, we will 3) define the effect of CMG helicase mutations on the human NK cell antiviral response. Using careful analysis of gene expression, phenotype and function, we will determine the timing and the nature of developmental deregulation in NK cell developmental intermediates with hypomorphic replisome mutations. These aims we will advance a novel new paradigm in human NK cell differentiation, namely the specific requirement for proliferation and cell cycle control for NK cell terminal maturation. These studies have significant clinical importance for understanding the differentiation of NK cells in the unique milieu following hematopoietic stem cell transplant. Defining the role of proliferation in the generation of mature NK cell effectors will enable the better control of these cells to prevent graft vs. host disease and promote their natural anti-tumor immunity.

项目总结